ICAM1 and colorectal carcinoma: ICAM-1 increased lymphocytes recruitment, promoted lymphocytes to attach to CRC cells and lymphocyte-mediated tumor lysis, which may improve the immunosurveillance and restrict tumor metastasis (20, 24).